Results 241 to 250 of about 328,314 (314)
Efficient Estimation Methods for the QR Distribution with Type-II Censored Data: An Empirical Validation on Lung Cancer Prognosis. [PDF]
Ramzan Q, Amin M, Alghamdi S, Alharbi R.
europepmc +1 more source
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu +8 more
wiley +1 more source
Reduction techniques for survival analysis. [PDF]
Piller J +8 more
europepmc +1 more source
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha +4 more
wiley +1 more source
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef +2 more
wiley +1 more source
Temporal dynamics of prognostic factors in breast cancer survival. [PDF]
Tvete IF, Klemp M.
europepmc +1 more source
Modeling Disease-specific Survival in Observational Studies with Missing Cause of Death: Leveraging Information from Clinical Trial Data. [PDF]
Wang Y, Shen Y, Ning J.
europepmc +1 more source
Estimation of combined treatment effects by restricted mean survival time. [PDF]
Alger E, Robertson DS, Burdon AJ.
europepmc +1 more source
Distinguishing between the exponential and Lindley distributions: An illustration from biological psychology. [PDF]
Chowdhury S +3 more
europepmc +1 more source

